2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th ed
|
|
|
- しょうすけ ますはら
- 7 years ago
- Views:
Transcription
1 / / 1) Basic Pathology (7 th edition): Kumar V, Cotran RS, Robbins SL (eds.), W.B. Saunders, ) Essential Pathology (3 rd edition): Rubin E (ed), Lippincott Williams & Wilkins, ) ) ) 6)
2 2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th edition): Rubin E, Gorstein F, Rubin R, Schwarting R, Strayer D (eds.), Lippincott Williams & Wilkins, ) Andersons Pathology10th edition: Damjanov I and Linder J (eds.), Mosby, 1996
3
4
5 Churg-Strauss B C D E.
6
7 A B C D E F G. H. I. 1) 2) 3) 4) ( 5) Gastrointestinal stromal tumor 6) 1) 2) 3) ( )4) ( )5) 6) 7) 3) 4)
8 7 4 Barrett Wegener s granulomatosis
9 A Barrett B A B C MALT lymphoma X X US, CT MRI
10 A I. B I II. C I II. Bowen Paget Ewing A B 19
11 , Marfan s Buerger sdisease B T T /
12 Peutz-Jeghers : : ( ) ( ) CIS Hirschsprung Congenital megacolon
13 MALT Paget Pagetoid
14
Microsoft Word - 三重大学版PBLマニュアル.doc
Problem-based Learning PBL * 1 * 2 * 1 Problem-based Learning Project-based Learning * 2 1 15 2 reflection self-directed learning (PBL-tutorial) (Task-based Learning, Project-based Learning) 11 3 4 (Theoretical
1
1 1 2 3 4 2 3 4 5 R 6 7 1 2 3 4 1 2 3 4 8 1 1 2 3 4 1 2 3 9 10 R A 85 U 11 8605 66 E 8 8 0 0 6 U W 6 B 38 U W6B28 U 12 W A 65 14 U W A 5B 12 U 6B 65 13 R A 85 F 14 15 16 17 18 19 20 21 22 23 24 25 26 27
124
[ ] [ ] 18 123 124 ( ) 125 126 127 128 5,683,062 2,306,419 18.2 14.0 12 5389 87 13 257 88 12 22 27 56.7 41.6 1 1.7 15 129 55 38.8 13.3 15 2004 15 1 3 84.8 29.3 1 23.9 38.0 10 10 35 35 15 5 56.5.31 55.4.1
2013 5
12 (SL) (L) (SL) 2013 5 5 29 () 4 ( ) 7 17 20 ( ) 2 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 14. 4.17 14. 5. 1 14. 5. 8 14. 5.22 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 4 10 7 7 10 7 31 8 14.4.10 14.7.10 14.7.31
1000
1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 SL 1000 1000 1000 1000 1000 1000 1000 1000 1000 ( 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
取扱説明書
ED-601 ED-501 ED-401 2 3 4 23 14 5 6 18 10 7 1 2 6 3 4 8 9 16 16 16 12 1 2 18 10 2 1 5 12 11 1 2 1 2 12 1 2 13 16 14 3 2 4 1 1 2 16 3 4 18 15 1 2 16 2 3 1 1 2 3 18 17 18 22 19 D A C 20 A B 22 B C D 22
野岩鉄道の旅
29th 5:13 5:34 5:56 6:00 6:12 6:20 6:21 6:25 6:29 6:31 6:34 6:38 6:40 6:45 6:52 6:56 7:01 7:07 7:11 7:32 7:34 7:50 7:58 8:03 8:17 8:36 8:44 5:50 5:54 6:15 6:38 6:39 6:51 6:59 6:59 7:03 7:08 7:08 7:11 7:15
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58
untitled
i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)
23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23
平成１８年度「商品先物取引に関する実態調査」報告書
... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...
18 (1) US (2) US US US 90 (3) 2 8 1 18 108 2 2,000 3 6,000 4 33 2 17 5 2 3 1 2 8 6 7 7 2 2,000 8 1 8 19 9 10 2 2 7 11 2 12 28 1 2 11 7 1 1 1 1 1 1 3 2 3 33 2 1 3 2 3 2 16 2 8 3 28 8 3 5 13 1 14 15 1 2
第122号.indd
-1- -2- -3- 0852-36-5150 0852-36-5163-4- -5- -6- -7- 1st 1-1 1-2 1-3 1-4 1-5 -8- 2nd M2 E2 D2 J2 C2-9- 3rd M3 E3 D3 J3 C3-10- 4th M4 E4 D4 J4 C4-11- -12- M5 E5 J5 D5 C5 5th -13- -14- NEWS NEWS -15- NEWS
104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26
25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (
2) Andrews and Domonkos: Hauseweives' eczma, Disease of the Skin 5 th Ed., Saunders, Philadelphia and London, 69, 19 63. 3) Pillsbury et al.: Dermtitis and Eczema of the Hands, Contact dermatitis, Dermatology,
取扱説明書[N-01B]
![取扱説明書[N-01B]](/thumbs/39/20475078.jpg "取扱説明書[N-01B]")
433 o 434 u 435 i81 p 436 i56 i70 i86 i93 437 438 i66 i63 i15 i52 i57 i36 8 i40 i41 i10 i29 i61 i60 i31 i39 i50 i13 i64 i54 i89 439 440 i89 i20 i58 i68 i90 i65 i55 i76 i75 i77 i18 i84 i51 i94 i17 2 441
untitled
5 10% 1 13 15cm 3 4cm 2 RS P Rb Ra S RS Ra Rb P 4 S RS CT MRI Stage 0 Stage I Stage I Stage II Ra Rb P TEM TEM ISR TEM Transanal endoscopic microsurgery 5cm 4cm 5cm TEM 1 2 3 10cm RS 6cm Ra 4cm Rb 2cm
02-06プ_一般ポスター_0407.indd
一般ポスター工学基礎一般ポスター工学基礎 イメージング 信号処理 5 月 7 日 ( 土 )6:0-7:0 ポスター 展示会場 座長 : ( 栃木県総合文化センター 階第 4 ギャラリー ) 90- 基 P-00 CT S6 90- 基 P-00 S6 90- 基 P-00 S6 90- 基 P-004 S6 90- 基 P-005 S64 90- 基 P-006 S64 90- 基 P-007 STC
R&D R&D ~13 EU 10 EU EU
2002 2003 3 1983 1 19 2002 11 12 17 6 2002 986 862 111 13 312 304 7 1 R&D R&D 82 78 4 2002 1 2002 12 12~13 EU 10 EU EU 2004 5 1 25 2003 3 2003 3 () 2002 11 12 17 6 308 1983 19 973 862 111 2002 2001 23
株式会社ウェッズ
39th 1 2 39th 25,000 500 300 20,000 15,000 400 300 200 10,000 5,000 200 100 100 0 0 0 16,000 50 5 12,000 8,000 4,000 40 30 20 10 4 3 2 1 0 0 0 3 4 39th 5 6 39th 7 N E W P R O D U C T S 8 39th 9 10 CO.,LTD.
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
平成16年度卒業論文
16 1050135 1....2 2....3 2.1...3 2.2...4 2.3...5 3....6 3.1 (3)...6 3.2 (4)(5)...7 4....9 4.1...9 4.2...10 4.3...10 5....12 5.1...12 5.2...14 5.2.1...14 5.2.2...16 5.2.3...18 5.2.4...18 5.2.5...20 5.2.6...23
Microsoft Word - 平成20年度シラバス最終.doc
平成 20 年度医学科 : 臨床系 1. 科目の要約 1) 授業科目名 : 系統病理学 2) 対象学生 : 系統講義, 実習 :M2 3) 担当責任教官名 : 深山正久 ( 病理学講座 人体病理学 病理診断学分野内線 23343,23344) http://pathol.umin.ac.jp/ 4) 授業の目標 : 全身の各臓器の病理学について学習する. 臨床医学の習得 知識の整理に役立つことを第一の目標とするが,
1 Francesca Laylah Jamilah 108 iryou/iryou/topics/tp html Fran
108 Francesca Laylah Jamilah 2015.11.27 1 2 2 2 3 3 3.1 A............................................... 3 3.2 B............................................... 13 3.3 C...............................................
10 10 10 1 2 3 4 2 2 4 5 6 7 8 1 9 1011 S 10 1 2 3 4 5 10 10 10 1 2 3 4 5 6 2 7 8 9 10 10 2 14 3 2 4 10 11 12 13 14 1521 15 16 15 16 ( ) 17 18 19 20 21 1 10 4 1 2 5 3 2 II 2 3 ( ) 5 21 5 22 2 3 23
,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,
1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20
北辰同窓会36号-02.21修正
36 FEB, 2011 20112 36 1 GDPOECD 1.5 0.1910 1 2 4 29 Web 40 3,500 22 9 1 22 4 3,279 6 6 6 6 22 7 28 208 1971 9 1976 3 1976 4 1977 11 1983 7 1989 5 Russell Ross 1990 5 1994 7 2002 4 2004 8 1122 9 125 8 313
肝臓病教室201207v2配布用.pptx
24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0
8 8 0
,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7
1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%
2018表紙.indd
8 57 60 3 11 2018 2 2018 2 3 1 ISBN 2 230 3 http:// www.unp.or.jp 1 412 2,000 320 2,000 352 1,600 268 1,800 1982 86 195 21 1987 978-4-930689-67-2 SDI 1989 978-4-8158-0116-8 1983 978-4-930689-08-5 1984
表 参照文献 ( 文献 ). 185, Expert Nurse. 1211, suppl, , CNS 2000, , , , 4
研究報告 がん看護専門看護師のコンサルテーション * についての概念分析 要旨 Walker Avant2005 CNS Key words はじめに 1996 2012 3 10 795 Certified Nurse SpecialistCNSCNS 327 1 CNS 2 CNS 3 4 5 6 CNS CNS 方法 Walker Avant 7 2012 8 1 2013 2 27 連絡先
83
Candida sppmssa Haemophilus influenzae consolidation consolidation consolidation consolidation consolidation consolidation knuckle sign Westermark sign Hampton s hump Borchardt enteropathy-associated
Anatomical Names of Fossae and Foveae in Skeleton Shun-ichi Shikano and Yasuo Yamashita Section of Maxillofacial Anatomy, Department of Maxillofacial Biology, Division of Maxillofacial/Neck Reconstruction,
CONTENTS 1.1 2 1.2 15 1.3 25 1.4 35 1.5 46 1.6 63 1.7 74 1.8 82 1.9 94 1.10 108 1.11 118 Topics DTI 126 Topics 129 Topics DESIGNR 132 Topics 136 iv Topics 139 2.1 144 2.2 154 2.3 165 2.4 177 3.1 192 3.2
E3200 BV FOLFOX4 FOLFOX4 PFS % 0.42, 0.65 p< log-rank % FOLFOX4 8.6% FOLFOX % FOLFOX4 259/ % FOL
E3200 BV FOLFOX4 FOLFOX4 PFS 4.5 7.5 0.518 95% 0.42, 0.65 p
OJT OJT 2 00S012L22 1. 5. 2. 6. 3. 7. 4. 20 2011 4 2013 2013415 2013 10 15 20 2011 4 2013 2013 00S012L22 00S012L22 5. 6. 7. 3. 2. 1. 4. L1 L2 L3 L4 PC 00C001L11 00C002L11 00C003L11
ﾌﾟﾛｸﾞﾗﾑ・抄録集.indd
20th Annual Meeting of the Japanese Society for Oral Mucous Membrane 21st Annual Meeting of the Japanese Society of Oral Pathology 2 3 4 5 6 7 8 9 10 11 12 14 15 16 17 18 19 20 21 22 23 24 25 28 29
2006年度卒業論文
2006 1 3 2 8 14 4 30 1 21 2 I 1 16 2 18 3 16 II D B 1 1 1 14 1 15 10.6 2 59 63 59 63 5 20 117.4 3 15 23,000 4 15 80 5 2004 67 1 2002 2 2002 6 3 13 4 1990 4 391395 4 http://www.ccaj-found.or.jp/ 5 1994
1 2 3 4 5 1 1:30 NPO 16 1 19 16 2 17-6 - 10 2008 2010 120 150 IT( ) 60 21 40-7 - - 8-10 ( ) NPO 2 10 16:40-9 - 10 ii NPO NPO ( ) ( ) 11 12 13 14 15 22 26 27 28 29 30 31 32 33 34 m3 m3
44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
01 98で。中華人民共和国 表紙鑑.doc
2004 4 6 R/D 2004 8 23 R/D 2004 10 18 5 R/D 2004 10 i 2050 26% 16.55% 2001 2010 7,000 1.35 2,700 ODA 93NGO 6 NGO 5 2,100 / 2004 10 2009 9 5 5.5 * C/P 30 6 5 2,100 16.55%2003 0.345 km 2 356 km 2 37%1999
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2 1 2 1 Department of Clinical Pharmacotherapy, Hiroshima
PowerPoint プレゼンテーション
マグロウヒルアクセスメディシン McGraw-Hill s ACCESSMedicine - クイック レファレンス ガイド 医学テキストの利用について クイック レファレンス ガイド医学テキストの利用 1. 収録コンテンツ Clinical Library LANGE Educational Library ACCESSMedicineは毎日更新されています 2.ACCESSMedicine にアクセス
13,825,228 3,707,995 26.8 4.9 25 3 8 9 1 50,000 0.29 1.59 70,000 0.29 1.74 12,500 0.39 1.69 12,500 0.55 10,000 20,000 0.13 1.58 30,000 0.00 1.26 5,000 0.13 1.58 25,000 40,000 0.13 1.58 50,000 0.00 1.26
JPN-1
EF70-200mm f/2.8l IS II USM JPN JPN-1 a JPN-2 JPN-3 1. JPN-4 2. 3. JPN-5 4. JPN-6 5. JPN-7 6. JPN-8 7. JPN-9 JPN-10 8. 9. JPN-11 10. JPN-12 11. 12. 13. JPN-13 14. JPN-14 JPN-15 canon.jp/ef 050-555-90001
untitled
436 2112 12 436 2112 12 200912 12 800 900 1000 1100 1200 1300 1400 830 5F 900949 9491031 11051140 11401201 12061300 857900 10311050 10501105 13051340 13401422 5F 830 10301700 4F 403 11001150 5F 11551245
ito.dvi
1 2 1006 214 542 160 120 160 1 1916 49 1710 55 1716 1 2 1995 1 2 3 4 2 3 1950 1973 1969 1989 1 4 3 3.1 3.1.1 1989 2 3.1.2 214 542 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
1,000 700-1 -
23 9 () - 0 - 1,000 700-1 - 2 3 ( 16:0017:00 ( 8:15 8:30 10:3010:50 8:00 8:10 8:10 9:30 11:0011:20 11:3015:30 16:0016:40 16:0016:10 16:50 21:00 4:00 4:006:00 6:00 6:1511:00 11:3012:00 12:3014:30 (1) ()
No ii
2005 6 1 2 200004 103/7-2000041037-1 3 4 5 JIS JIS X 0208, 1997 o È o http://www.pref.hiroshima.jp/soumu/bunsyo/monjokan/index.htm 200004 3 6 188030489521435 6119865 1220007 2 1659361903 3118983 16 381963
平成20年度 大学院シラバス（表紙）
20 平 成 28 年 度 大 学 院 シラバス 専 攻 分 野 /コース ( 英 文 名 ) 研 究 指 導 教 員 内 科 学 (リウマチ 膠 原 病 アレルギー 内 科 ) (Rheumatology and Allergy) 尾 崎 承 一 研 究 教 育 の 概 略 リウマチ 性 疾 患 およびアレルギー 疾 患 には 難 治 性 病 態 が 未 だに 多 く 確 立 されていな 治 療
表紙PDF用.indd
i ii iii iv v vi vii viii ix x xi xii xiii 2 3 4 5 6 7 8 9 10 11 12 13 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50A 50B 51A 51B 52 54 55
A 01 2 015 10 11 12 G 011 2 0111 67
66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012
i ii ( ) ( ) ( ) 462,891 525,032 502,164 230,636 CD CD 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 11 10 12 11 13 11 14 12 15 12 16 13 16 14 17 15 18 15 18 16 19 17 20 17 18 19
(2010) (1)AB... / 2 ()................................................................................................................... 5 (1)C... /
222010................................................... 2................................................ 2............................................ 151 (2010) (1)AB... / 2 ()...................................................................................................................